Ligand Pharmaceuticals | Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agenus USD 266K 30K 2025-03
Amgen USD 539M 1000K 2025-12
Anika Therapeutics USD 143K 1000 2025-03
Arrowhead Research USD 135.7M 2.44M 2025-09
Baxter International USD 683M 0 2024-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Enanta Pharmaceuticals USD 212K 1000 2023-12
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.03B 2.68B 2025-09
Heron Therapeutics USD 1.52M 14K 2024-09
Insmed USD 212.58M 210.76M 2025-09
Intrexon USD 0 0 2024-06
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
Ligand Pharmaceuticals USD 20K 0 2025-03
MacroGenics USD 63.26M 62.63M 2025-09
Merck USD 2.49B 15.79M 2025-09
Pacira USD 44.9M 44.85M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Rigel Pharmaceuticals USD 17K 158K 2024-06
Veracyte USD 78.67M 73K 2025-09


Ligand Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.